Amyloid-Related Imaging Abnormalities in the DIAN-TU-001 Trial of Gantenerumab and Solanezumab: Lessons from a Trial in Dominantly Inherited Alzheimer Disease.
Ann Neurol
; 92(5): 729-744, 2022 11.
Article
in En
| MEDLINE
| ID: mdl-36151869
Full text:
1
Collection:
01-internacional
Database:
MEDLINE
Main subject:
Alzheimer Disease
Type of study:
Clinical_trials
/
Observational_studies
/
Prevalence_studies
/
Risk_factors_studies
Limits:
Humans
Language:
En
Journal:
Ann Neurol
Year:
2022
Document type:
Article
Affiliation country:
Macao
Country of publication:
Estados Unidos